Global Cardiac Biomarker Market Research and Forecast 2018-2023

INDORE, India - Feb. 5, 2019 - PRLog -- "Increasing cases of cardiovascular diseases is driving the growth of cardiac biomarker market."

According to the OMR analysis, the global cardiac biomarker market is growing at a significant rate during 2018-2023. The global cardiac biomarker market has witnessed a significant growth due to increasing cases of cardiovascular diseases and rising healthcare expenditure. The global cardiac biomarker market is segmented on the basis of type, drugs, applications, end users and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, patent analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis and analyst insights.

Increasing prevalence of CVDs is the factor that is paving the growth of market. Cardiovascular diseases are estimated to be one of the major causes of mortality globally. According to WHO, CVD accounts for more than 17.3 million mortalities per year and the number of mortalities by CVD is further estimated to reach 23.6 million by 2030. According to American Heart Society, in 2017, CVD caused around 800 thousand mortalities in the US. Heart disease is the leading cause of mortality globally, and in the US alone, about 370 thousand Americans lose their lives every year. Direct and indirect costs associated with CVD is estimated to be around 316 billion. Rising CVD and patient pool require cardiac biomarkers to treat or lower the effect of CVD. Hence, rising CVD are estimated to augment the global cardiac biomarker market during the forecast period.

The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow at a stable CAGR. North American market is driven by is rising number of CVD patient pool in the US. In addition, rising healthcare expenditure and growing support from government organizations are paving the market growth. Asia Pacific market is expected to have the highest CAGR amongst all regions during the forecast period of 2018-2023. The increasing medical tourism in the APAC region and economic developments are supporting growth of this region.

The report covers
Comprehensive research methodology of global cardiac biomarkers market
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global cardiac biomarkers market
Insights about market determinants which are stimulating the global cardiac biomarkers market
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Full report of global cardiac biomarker market is available at https://www.omrglobal.com/industry-reports/cardiac-biomar...

For related reports please visit https://www.omrglobal.com/reports-category/healthcare/

About Orion Market Research

Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company provides quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.